257 related articles for article (PubMed ID: 12496442)
1. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice.
Langdon C; Kerr C; Tong L; Richards CD
J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin-M up-regulates VCAM-1 and synergizes with IL-4 in eotaxin expression: involvement of STAT6.
Fritz DK; Kerr C; Tong L; Smyth D; Richards CD
J Immunol; 2006 Apr; 176(7):4352-60. PubMed ID: 16547273
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M induction of eotaxin-1 expression requires the convergence of PI3'K and ERK1/2 MAPK signal transduction pathways.
Smyth DC; Kerr C; Li Y; Tang D; Richards CD
Cell Signal; 2008 Jun; 20(6):1142-50. PubMed ID: 18372159
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
Tong L; Smyth D; Kerr C; Catterall J; Richards CD
Cell Signal; 2004 Oct; 16(10):1123-32. PubMed ID: 15240007
[TBL] [Abstract][Full Text] [Related]
6. Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13.
Faffe DS; Flynt L; Mellema M; Moore PE; Silverman ES; Subramaniam V; Jones MR; Mizgerd JP; Whitehead T; Imrich A; Panettieri RA; Shore SA
J Allergy Clin Immunol; 2005 Mar; 115(3):514-20. PubMed ID: 15753898
[TBL] [Abstract][Full Text] [Related]
7. Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.
Kwofie K; Scott M; Rodrigues R; Guerette J; Radford K; Nair P; Richards CD
Respir Res; 2015 Feb; 16(1):14. PubMed ID: 25849622
[TBL] [Abstract][Full Text] [Related]
8. A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent.
Fritz DK; Kerr C; Fattouh R; Llop-Guevara A; Khan WI; Jordana M; Richards CD
J Immunol; 2011 Jan; 186(2):1107-18. PubMed ID: 21160052
[TBL] [Abstract][Full Text] [Related]
9. Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells.
Hurst SM; McLoughlin RM; Monslow J; Owens S; Morgan L; Fuller GM; Topley N; Jones SA
J Immunol; 2002 Nov; 169(9):5244-51. PubMed ID: 12391243
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tissue inhibitor of metalloproteinase-1 in fibroblasts and acute phase proteins in hepatocytes in vitro by mouse oncostatin M, cardiotrophin-1, and IL-6.
Richards CD; Kerr C; Tanaka M; Hara T; Miyajima A; Pennica D; Botelho F; Langdon CM
J Immunol; 1997 Sep; 159(5):2431-7. PubMed ID: 9278335
[TBL] [Abstract][Full Text] [Related]
11. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo.
Langdon C; Kerr C; Hassen M; Hara T; Arsenault AL; Richards CD
Am J Pathol; 2000 Oct; 157(4):1187-96. PubMed ID: 11021823
[TBL] [Abstract][Full Text] [Related]
12. The IL-6 family cytokines, interleukin-6, interleukin-11, oncostatin M, and leukemia inhibitory factor, enhance mast cell growth through fibroblast-dependent pathway in mice.
Gyotoku E; Morita E; Kameyoshi Y; Hiragun T; Yamamoto S; Hide M
Arch Dermatol Res; 2001 Nov; 293(10):508-14. PubMed ID: 11820727
[TBL] [Abstract][Full Text] [Related]
13. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1/2-pathway independent of p38(MAPK)/MK2.
Ehlting C; Böhmer O; Hahnel MJ; Thomas M; Zanger UM; Gaestel M; Knoefel WT; Schulte Am Esch J; Häussinger D; Bode JG
Cell Signal; 2015 Mar; 27(3):555-67. PubMed ID: 25562430
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M differentially regulates CXC chemokines in mouse cardiac fibroblasts.
Lafontant PJ; Burns AR; Donnachie E; Haudek SB; Smith CW; Entman ML
Am J Physiol Cell Physiol; 2006 Jul; 291(1):C18-26. PubMed ID: 16452159
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of eotaxin-1/CCL11 and eotaxin-3/CCL26 production by the TNF-alpha and IL-4 stimulated human lung fibroblast.
Rokudai A; Terui Y; Kuniyoshi R; Mishima Y; Mishima Y; Aizu-Yokota E; Sonoda Y; Kasahara T; Hatake K
Biol Pharm Bull; 2006 Jun; 29(6):1102-9. PubMed ID: 16755001
[TBL] [Abstract][Full Text] [Related]
17. Type I Interferon Signaling is Required for Oncostatin-M Driven Inflammatory Responses in Mouse Lung.
MacDonald K; Botelho F; Ashkar AA; Richards CD
J Interferon Cytokine Res; 2022 Nov; 42(11):568-579. PubMed ID: 36346324
[TBL] [Abstract][Full Text] [Related]
18. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression.
Zimmermann N; Hogan SP; Mishra A; Brandt EB; Bodette TR; Pope SM; Finkelman FD; Rothenberg ME
J Immunol; 2000 Nov; 165(10):5839-46. PubMed ID: 11067944
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.
Richards CD; Langdon C; Deschamps P; Pennica D; Shaughnessy SG
Cytokine; 2000 Jun; 12(6):613-21. PubMed ID: 10843736
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M, a multifunctional cytokine.
Tanaka M; Miyajima A
Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
